rs117632905

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 1P and 10B. PP3BP6BP7BS1BS2

The NM_001160372.4(TRAPPC9):​c.1407C>T​(p.Tyr469Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000964 in 1,614,206 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0015 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00091 ( 11 hom. )

Consequence

TRAPPC9
NM_001160372.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 0.335

Publications

2 publications found
Variant links:
Genes affected
TRAPPC9 (HGNC:30832): (trafficking protein particle complex subunit 9) This gene encodes a protein that likely plays a role in NF-kappa-B signaling. Mutations in this gene have been associated with autosomal-recessive cognitive disability. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2010]
TRAPPC9 Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal recessive 13
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • intellectual disability-obesity-brain malformations-facial dysmorphism syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

PP3
REVEL computational evidence supports a deleterious effect, 0.683
BP6
Variant 8-140360138-G-A is Benign according to our data. Variant chr8-140360138-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 130614.
BP7
Synonymous conserved (PhyloP=0.335 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00148 (226/152316) while in subpopulation EAS AF = 0.00231 (12/5194). AF 95% confidence interval is 0.00133. There are 2 homozygotes in GnomAd4. There are 152 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRAPPC9NM_001160372.4 linkc.1407C>T p.Tyr469Tyr synonymous_variant Exon 9 of 23 ENST00000438773.4 NP_001153844.1 Q96Q05-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRAPPC9ENST00000438773.4 linkc.1407C>T p.Tyr469Tyr synonymous_variant Exon 9 of 23 1 NM_001160372.4 ENSP00000405060.3 Q96Q05-1
TRAPPC9ENST00000520857.5 linkc.936C>T p.Tyr312Tyr synonymous_variant Exon 7 of 21 1 ENSP00000430116.1 H0YBR0
TRAPPC9ENST00000648948.2 linkc.1407C>T p.Tyr469Tyr synonymous_variant Exon 9 of 23 ENSP00000498020.1 Q96Q05-1

Frequencies

GnomAD3 genomes
AF:
0.00149
AC:
227
AN:
152198
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00231
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.0154
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000573
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.00210
AC:
528
AN:
251480
AF XY:
0.00207
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.000595
Gnomad EAS exome
AF:
0.00201
Gnomad FIN exome
AF:
0.0158
Gnomad NFE exome
AF:
0.000949
Gnomad OTH exome
AF:
0.00244
GnomAD4 exome
AF:
0.000910
AC:
1330
AN:
1461890
Hom.:
11
Cov.:
31
AF XY:
0.000908
AC XY:
660
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33480
American (AMR)
AF:
0.0000894
AC:
4
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000459
AC:
12
AN:
26136
East Asian (EAS)
AF:
0.00116
AC:
46
AN:
39700
South Asian (SAS)
AF:
0.000591
AC:
51
AN:
86258
European-Finnish (FIN)
AF:
0.0153
AC:
817
AN:
53420
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.000305
AC:
339
AN:
1112010
Other (OTH)
AF:
0.000944
AC:
57
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
89
177
266
354
443
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00148
AC:
226
AN:
152316
Hom.:
2
Cov.:
32
AF XY:
0.00204
AC XY:
152
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41544
American (AMR)
AF:
0.00
AC:
0
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.00231
AC:
12
AN:
5194
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4828
European-Finnish (FIN)
AF:
0.0154
AC:
164
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000573
AC:
39
AN:
68042
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
10
20
31
41
51
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000645
Hom.:
0
Bravo
AF:
0.000400
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.000436
EpiControl
AF:
0.000356

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TRAPPC9: BP4, BP7 -

Intellectual Disability, Recessive Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 23, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Oct 11, 2018
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
9.7
DANN
Benign
0.87
PhyloP100
0.34
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117632905; hg19: chr8-141370237; API